retatrutide is an incretin-based triple agonist adding GIP, GLP-1, and glucagon activity
Using both covers the full repair process in a way neither peptide manages on its own, which is the core rationale for the wolverine stack
The secondary outcomes were the change of mean arterial blood pressure (delta MAP, %), the kinetics of arterial blood pressure, gap CO 2 , gap CO 2 /oxygen arteriovenous difference ratio, oxygen delivery (DO 2 ), oxygen consumption (VO 2 ), arterial lactate, hematocrit, sodium, and chloremia over a period of 60 min
Schmidt et al
Investigation of combination therapies, including combinations of these peptides with each other or with other therapeutic modalities, could potentially improve therapeutic efficacy for certain applications